Profile data is unavailable for this security.
About the company
NAYA Biosciences, Inc. formerly INVO Bioscience, Inc. operates the fertility business, as well as its focus to the development of clinical-stage assets in oncology and autoimmune diseases. The Company’s initial pipeline includes two novel Flex-NK Bispecific Antibodies. NY-303: its GPC3-targeted FLEX-NK Bispecific Antibody for Hepatocellular Carcinoma (HCC). NY-338: its CD38-targeted FLEX-NK Bispecific Antibody for Multiple Myeloma (MM) & Autoimmune Diseases. Its lead GPC3-targeting FLEX-NK bispecific antibody is entering Phase I/II clinical trials and positioned as a monotherapy option to address the unmet needs of the of hepatocellular carcinoma (HCC) patients not responding to standard of care with checkpoint inhibitors. INVOcell is its novel, FDA-cleared and CE-marked intravaginal culture (IVC) device. It offers a viable alternative to vitro fertilization (IVF) that uses the female body for fertilization and incubation, keeping women at the center of the reproductive process.
- Revenue in USD (TTM)5.77m
- Net income in USD-7.08m
- Incorporated2005
- Employees25.00
- LocationNAYA Biosciences Inc5582 Broadcast CourtSARASOTA 34240United StatesUSA
- Phone+1 (978) 878-9505
- Websitehttps://www.invobioscience.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nu-Med Plus Inc | 0.00 | -112.13k | 1.97m | 2.00 | -- | -- | -- | -- | -0.0014 | -0.0014 | 0.00 | -0.0022 | 0.00 | -- | -- | 0.00 | -471.23 | -447.69 | -- | -- | -- | -- | -- | -- | -- | -21.34 | -- | -- | -- | -- | 3.56 | -- | -- | -- |
| Tivic Health Systems Inc | 1.11m | -6.75m | 2.05m | 9.00 | -- | 0.4883 | -- | 1.84 | -4.33 | -4.33 | 0.5469 | 0.6779 | 0.2373 | 0.9156 | 76.76 | 123,666.70 | -143.94 | -- | -176.98 | -- | 27.85 | -- | -606.47 | -- | 6.59 | -- | 0.00 | -- | -36.09 | -- | 18.34 | -- | -- | -- |
| Helius Medical Technologies Inc | 594.00k | -8.84m | 2.11m | 22.00 | -- | 0.2851 | -- | 3.55 | -10.68 | -10.68 | 0.5042 | 1.98 | 0.0606 | 0.7486 | 4.48 | 27,000.00 | -90.17 | -98.37 | -110.33 | -143.57 | 12.79 | 37.27 | -1,487.54 | -1,580.66 | 3.80 | -- | 0.00 | -- | -18.17 | 6.14 | 37.11 | -- | -41.95 | -- |
| Venus Concept Inc | 69.81m | -49.93m | 2.43m | 304.00 | -- | 0.6567 | -- | 0.0348 | -8.38 | -8.38 | 11.92 | 0.5103 | 0.751 | 1.03 | 2.25 | 229,634.90 | -53.53 | -32.71 | -82.19 | -44.01 | 68.39 | 68.16 | -71.28 | -48.50 | 1.30 | -2.75 | 0.9133 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
| HeartSciences Inc | 18.60k | -7.29m | 2.47m | 15.00 | -- | 0.4125 | -- | 132.58 | -5.65 | -5.65 | 0.0011 | 6.55 | 0.0035 | 0.0092 | -- | 1,240.00 | -135.14 | -- | -193.38 | -- | 67.31 | -- | -39,193.76 | -- | 4.02 | -20.72 | 0.0777 | -- | 261.17 | -- | -3.95 | -- | -- | -- |
| Leafbuyer Technologies Inc | 5.60m | -709.43k | 2.50m | 12.00 | -- | -- | -- | 0.4466 | -0.0071 | -0.0071 | 0.0562 | -0.0168 | 4.14 | -- | 51.16 | 466,779.20 | -52.37 | -27.14 | -- | -- | 36.63 | 34.92 | -12.67 | -20.65 | -- | -4.77 | -- | -- | 10.03 | 25.63 | -21.23 | -- | -- | -- |
| NanoVibronix Inc | 3.37m | -2.82m | 2.60m | 10.00 | -- | 0.6778 | -- | 0.7694 | -1.32 | -1.32 | 1.50 | 1.02 | 0.7081 | 0.431 | 12.05 | 337,300.00 | -59.12 | -116.16 | -122.41 | -169.36 | 64.57 | 50.47 | -83.49 | -570.47 | 1.16 | -14.77 | 0.00 | -- | 203.59 | 48.33 | 31.88 | -- | -34.02 | -- |
| Avinger Inc | 7.43m | -15.34m | 2.62m | 68.00 | -- | 0.2027 | -- | 0.3529 | -12.13 | -12.13 | 5.83 | 4.05 | 0.434 | 1.23 | 8.03 | 109,250.00 | -113.20 | -70.93 | -1,387.68 | -131.57 | 19.96 | 30.87 | -260.86 | -208.91 | 1.20 | -11.66 | 0.3428 | -- | -7.51 | -0.6736 | 32.76 | -- | -24.21 | -- |
| ReShape Lifesciences Inc | 8.05m | -9.02m | 2.85m | 31.00 | -- | 0.9381 | -- | 0.3539 | -74.86 | -74.86 | 27.64 | 5.99 | 0.882 | 0.8035 | 4.79 | 259,548.40 | -98.88 | -136.06 | -169.55 | -194.32 | 67.47 | 56.30 | -112.11 | -408.36 | 0.8875 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
| Vycor Medical Inc | 1.36m | -506.30k | 2.86m | 8.00 | -- | -- | -- | 2.10 | -0.0155 | -0.0156 | 0.0417 | -0.1081 | 1.43 | 0.6694 | 5.08 | 170,011.30 | -19.13 | -47.86 | -- | -- | 89.23 | 89.60 | -13.38 | -35.42 | 0.0987 | -0.8001 | -- | -- | 19.43 | -0.6542 | 46.49 | -- | -31.77 | -- |
| SINTX Technologies Inc | 3.13m | -8.60m | 2.91m | 43.00 | -- | 0.1836 | -- | 0.9322 | -271.52 | -271.52 | 16.44 | 11.82 | 0.1818 | 1.77 | 7.63 | 72,697.67 | -50.01 | -45.71 | -62.67 | -57.36 | 67.72 | 58.47 | -275.14 | -681.80 | 1.79 | -- | 0.0265 | -- | 68.29 | 94.24 | 49.75 | -- | 54.10 | -- |
| NAYA Biosciences Inc | 5.77m | -7.08m | 3.30m | 25.00 | -- | -- | -- | 0.5715 | -3.24 | -3.24 | 2.44 | 0.3529 | 0.4677 | 12.00 | 34.74 | 230,781.20 | -57.44 | -94.63 | -116.03 | -151.45 | 44.89 | 74.91 | -122.80 | -343.11 | 0.2686 | -4.75 | 0.6588 | -- | 267.38 | 43.62 | 26.24 | -- | 87.09 | -- |
| AccuStem Sciences Inc | 0.00 | -1.65m | 4.08m | 3.00 | -- | -- | -- | -- | -0.1454 | -0.1454 | 0.00 | -0.2542 | 0.00 | -- | -- | 0.00 | -551.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 45.26 | -- | -- | -- |
| Fuse Medical Inc | 18.40m | 3.63m | 4.43m | 31.00 | 1.67 | -- | 1.20 | 0.2409 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
| Reflect Scientific Inc | 1.73m | -53.09k | 4.45m | 7.00 | -- | 2.26 | 57.72 | 2.56 | -0.0006 | -0.0006 | 0.0203 | 0.023 | 0.7197 | 0.8463 | 17.05 | 247,638.60 | -2.20 | 11.10 | -2.59 | 13.21 | 58.19 | 62.48 | -3.06 | 10.00 | 5.68 | -- | 0.00 | -- | -47.09 | -6.99 | -613.46 | -- | -- | -- |
Data as of Nov 13 2024. Currency figures normalised to NAYA Biosciences Inc's reporting currency: US Dollar USD
5.67%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| CWC Advisors LLCas of 30 Sep 2024 | 100.48k | 2.57% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 54.06k | 1.38% |
| Geode Capital Management LLCas of 30 Jun 2024 | 32.61k | 0.84% |
| Two Sigma Securities LLCas of 30 Jun 2024 | 15.97k | 0.41% |
| Virtu Americas LLCas of 30 Jun 2024 | 12.41k | 0.32% |
| Tower Research Capital LLCas of 30 Jun 2024 | 5.11k | 0.13% |
| City National Rochdale LLCas of 30 Jun 2024 | 438.00 | 0.01% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Jun 2024 | 250.00 | 0.01% |
| Qube Research & Technologies Ltd.as of 30 Jun 2024 | 100.00 | 0.00% |
| Strategic Advisers LLCas of 30 Jun 2024 | 75.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
